Position in AVNS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$18,406,945
+$17,171,284 QoQ
Shares Held
739,829
+758.0% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#18
of 276 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVNS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $726,781,729 across 37 Medical Devices names. AVNS ranks #6 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
1,090,163 | $344,218,967 | |
| 2 | MDT |
Medtronic plc
|
986,367 | $77,163,489 | |
| 3 | GKOS |
GLAUKOS Corp
|
491,636 | $68,711,047 | |
| 4 | ABT |
Abbott Laboratories
|
740,808 | $67,220,917 | |
| 5 | EW |
Edwards Lifesciences Corp
|
456,202 | $41,268,032 | |
| 6 | AVNS |
Avanos Medical, Inc.
This page
|
739,829 | $18,406,945 | |
| 7 | BBNX |
Beta Bionics, Inc.
|
855,682 | $13,408,536 | |
| 8 | AXGN |
Axogen, Inc.
|
253,498 | $11,709,072 |
All Filings in AVNS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,406,945 | 739,829 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $1,235,661 | 86,229 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $232,575 | 14,609 | Shares | Sole | 2025-02-14 | |
| 2023-06-30 | $336,931 | 13,182 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $671,608 | 30,836 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $9,678,606 | 354,009 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,676,341 | 288,846 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,675,205 | 307,909 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,327,012 | 330,994 | Shares | Sole | 2021-12-01 | |
| 2020-09-30 | $6,907,800 | 207,941 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||